Some users of weight loss jabs have reported losing more than just the pounds-they've taken to online forums in their ...

Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity and related metabolic issu ...

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most ...

In its various forms, including the gastric-band surgery that Sheree first had, the treatment induces substantial and sustained weight loss and improves obesity-related health conditions.

In the real world, the use of semaglutide (Wegovy) and tirzepatide (Zepbound) produce far less weight loss than in the randomized clinical trials, largely because people discontinue using them ...

Protein bars offer a convenient way to top up essential nutrients when on the move, but they could also help super-boost weight loss , new research has found.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men. What’s not clear is why.

People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide, the active ingredient in Wegovy, ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of treatment Tirzepatide users experienced greater waistline reduction (7. ...

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.